Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Public awareness of the hearing loss-dementia link and self-reported behavioral changes in middle- to older-aged Canadians 2026-09-26
  2. Patterns of modifiable lifestyle, behavioural and health-related risk factors and their associations with incident dementia in UK Biobank 2026-09-25
  3. Excess hypoglycaemia-related hospitalisation in older adults with comorbid type 2 diabetes and dementia: a UK Biobank cohort study 2026-09-16

Studies

1,143 studies carry this tag.

Date range

1978 to 2026

Top journals

  • Neurology 134
  • Alzheimer s & Dementia 52
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 33
  • Journal of the American Geriatrics Society 32
  • JAMA neurology 28

362 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Cardiovascular contributions to dementia: Examining sex differences and female‐specific factors

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer s & Dementia 2025-08-01 Risk factors

    Growing evidence underscores the importance of cardiovascular contributions to Alzheimer's disease and related dementias (AD/ADRD).

  2. Dementia risk reduction in China: Country‐specific estimates of modifiable risk factors and population attributable fractions (PAFs)

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer s & Dementia 2025-08-01 Prevention and risk

    The 12 risk factors account for 60.3% of dementia cases in China, including 14.0% in early life, 8.8% in midlife, and 37.5% in later life.

  3. Incorporating RHR into the CAIDE model significantly improved predictive accuracy across Black African, Asian, White, and Native Hawaiian populations (mean AUC range: 0.80-0.91).

  4. Cross-sectional and longitudinal associations of circulating bile acids and dementia: a systematic review

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. GeroScience 2025-07-23 Inflammation and the immune system

    Bile acids (BAs) may contribute to dementia by regulating neuroinflammation and influencing gut-brain axis signaling, especially in Alzheimer's disease (AD).

  5. Glucagon-Like Peptide-1 Receptor Agonists and Incidence of Dementia Among Older Adults With Type 2 Diabetes: A Target Trial Emulation

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. Annals of Internal Medicine 2025-07-22 Prevention and risk

    Among older adults with diabetes, no clear evidence was found that the incidence of dementia differed overall between patients using GLP-1RAs versus DPP4is.

  6. High-fat diet may increase the risk of insulin resistance by inducing dysbiosis

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Metabolism Open 2025-07-22 Prevention and risk

    High-fat diet (HFD) poses various health risks, such as obesity, insulin resistance (IR), fatty liver, gut microbiota dysbiosis, cognitive impairment, inflammation, and oxidative stress.

  7. Multidimensional sleep profiles via machine learning and risk of dementia and cardiovascular disease

    ✓ Peer-reviewed alzhub usefulness score 54 out of 100. Communications Medicine 2025-07-22 Digital health tools

    We identify three distinct profiles: active healthy sleepers (AHS; 64.0%), fragmented poor sleepers (FPS; 14.1%), and long and frequent nappers (LFN; 21.9%).

  8. BackgroundDementia is a syndrome characterized by a decline in cognitive function, with Alzheimer's disease (AD) being the most common type.

  9. Genetic Correlates of Presenile Dementia and Cognitive Decline in the Armenian Population Following COVID-19: A Case-Control Study

    ✓ Peer-reviewed alzhub usefulness score 42 out of 100. International Journal of Molecular Sciences 2025-07-20 Getting a diagnosis

    The presence of cognitive lapses in the post-COVID-19 period, particularly among younger individuals, suggests a potential genetic predisposition.

  10. Association of vitamin B12 deficiency in a dementia cohort with hippocampal atrophy on MRI

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. The Journal of Prevention of Alzheimer s Disease 2025-07-17 How common it is

    • This analysis consists of 567 participants revealed that vitamin B12 deficiency, not folate or vitamin B1 deficiency was associated with hippocampal atrophy detected by MRI-VSRAD analysis. • Vitamin B12 deficiency was associated with hyperhomocysteinemia. • Clear correlations were observed between hippocampal atrophy and vitamin B12 value.

  11. Adherence to four dietary indices and the risk of all‐cause and cause‐specific dementia: Findings from the UK Biobank study

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Diabetes Obesity and Metabolism 2025-07-16 Long-term cohort studies

    The analysis included 121 521 participants (mean age: 55.7 years; 53.5% women), followed for a median of 10.9 years.

  12. Association of heel bone mineral density with incident dementia among ageing adults: a population-based study from the UK Biobank

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Aging Clinical and Experimental Research 2025-07-16 Long-term cohort studies

    ) had a 14% increase in the rate of dementia incidence (HR 1.14, 95% CI 1.06-1.23; P <.001), and each standard deviation (SD) decrease in eBMD was associated with a 49% increase in dementia risk (HR 1.49, 95% CI 1.19-1.86; P <.001).

  13. Associations of cardiovascular health assessed by life’s crucial 9 with incident cardiovascular disease and dementia: A prospective cohort study

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. The Journal of Prevention of Alzheimer s Disease 2025-07-15 How common it is

    Of 289,649 included participants, 137,480 (47.5 %) were male, and the mean age was 56.6 ± 8.1 years.

  14. Risk of dementia following gabapentin prescription in chronic low back pain patients

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Regional Anesthesia & Pain Medicine 2025-07-10 How common it is

    26,416 adults we analyzed following propensity-score matching.

  15. Associations of cardiometabolic multimorbidity with all-cause dementia, alzheimer’s disease, and vascular dementia: a cohort study in the UK biobank

    ✓ Peer-reviewed alzhub usefulness score 56 out of 100. BMC Public Health 2025-07-07 How common it is

    Compared with those without CMD, those with CMD multimorbidity had an elevated risk of ACD (hazard ratio [HR]: 2.27, 95% confidence interval [95% CI]: 1.95-2.63), AD (HR: 1.49, 95% CI: 1.13-1.97), and VD (HR: 3.70, 95% CI: 2.93-4.69).

  16. Cognitive Dysfunction and Dementia in Type 2 Diabetes Mellitus: Insights into Mechanisms, Models, and Therapeutics

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. ACS Pharmacology & Translational Science 2025-07-07 Risk factors

    Diabetic-related cognitive dysfunction, especially mild cognitive impairment (MCI), is a serious complication of type 2 diabetes mellitus (T2DM).

  17. Multi-dimensional sleep health and dementia risk: a prospective study in the UK Biobank

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. BMC Medicine 2025-07-07 Risk factors

    There were 7458 incident all-cause dementia cases (1636 VaD, 3376 AD) after 4,165,352 person-years of follow-up.

  18. Long‐Term Incidence of Dementia Following Transient Ischemic Attack: A Longitudinal Cohort Study

    ✓ Peer-reviewed alzhub usefulness score 56 out of 100. Journal of the American Heart Association 2025-07-04 How common it is

    We found no significant difference in dementia incidence over a 20‐year follow‐up period compared with matched TIA‐free controls.

  19. Sex differences in risk factors associated with Alzheimer’s dementia patients with irritability and anger

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Archives of Gerontology and Geriatrics Plus 2025-07-03 Risk factors

    This study reveals key sex differences in ADIA patients.

  20. Iron species in cerebrospinal fluid and dementia risk in subjects with mild cognitive impairment: A cohort study

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. NeuroToxicology 2025-07-02 How common it is

    In this cohort, 28 participants developed Alzheimer's dementia, 5 frontotemporal dementia, 2 Lewy body dementia, and 2 vascular dementia during the follow-up.

  21. Neighborhood deprivation and mortality among people with Alzheimer's disease and related dementia

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of Alzheimer s Disease 2025-07-02 Risk factors

    BackgroundThere are limited studies quantifying the extent to which neighborhood deprivation affects mortality in individuals living with Alzheimer's disease (AD) and AD-related dementias (AD/ADRD).ObjectiveTo quantify to what extent neighborhood deprivation affects adverse outcomes in individuals living with AD/ADRD.MethodsWe identified individuals with AD/ADRD using a 15% random sample of national Medicare fee-for-service beneficiaries.

  22. Contribution of Modifiable Midlife and Late-Life Vascular Risk Factors to Incident Dementia

    ✓ Peer-reviewed alzhub usefulness score 69 out of 100. JAMA Neurology 2025-07-01 How common it is

    A total of 7731 participants were included in analysis of risk factors measured at age 45 to 54 years (4494 female [58%]; 2207 Black [29%]; 5524 White [71%]), 12 274 contributed to analysis of risk factors measured at age 55 to 64 years (6698 female [55%]; 2886 Black [24%]; 9388 White [76%]), and 6787 contributed to analysis of risk factors measured at age 65 to 74 years (3764 female [56%], 1375 Black [20%]; 5412 White [80%]).

  23. Development of a midlife-specific CogDrisk algorithm (CogDrisk-ML) to enable validated implementation of dementia risk assessment from midlife to late life

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Age and Ageing 2025-07-01 Brain tissue and pathology

    CogDrisk-ML outperformed CAIDE in the UK Biobank and Whitehall II cohorts; however, it provided similar C statistics in the ARIC dataset.

  24. Loneliness trajectories and dementia risk: Insights from the HUNT cohort study

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2025-07-01 Getting a diagnosis

    In the fully adjusted model, the odds ratio (OR) for persistent loneliness was 1.47 (95% confidence interval [CI] 1.10, 1.95).

  25. Mechanisms of vitamin d deficiency as a risk factor for post-stroke depression, dementia, delirium, and fatigue: A promising therapeutic modality

    ✓ Peer-reviewed alzhub usefulness score 29 out of 100. Journal of Affective Disorders Reports 2025-07-01 Clinical safety

    Acute ischemic stroke often results in a multitude of neuropsychiatric complications, including depression, dementia, delirium, and fatigue.

  26. Obstructive sleep apnoea and risk of dementia: a Danish population-based cohort study

    ✓ Peer-reviewed alzhub usefulness score 56 out of 100. BMJ Neurology Open 2025-07-01 How common it is

    We identified 62 928 patients with OSA and 62 928 in the propensity score-matched comparison cohort (76% male, median age 52 years).

  27. Relationship between cellular aging, perceived stress, and cardiometabolic disease risk in Black family caregivers of persons with dementia

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Alzheimer s & Dementia 2025-07-01 Disparities

    Shorter telomeres were linked to stress, poor sleep, inflammation, and cardiometabolic markers.

  28. Sensory impairment and dementia risk among older adults in rural South Africa

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Alzheimer s & Dementia 2025-07-01 Disparities

    Half of the participants were over 70, with no formal education.

  29. Sex differences in modifiable dementia risk factors: Findings from the Rush Memory and Aging Project

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Alzheimer s & Dementia 2025-07-01 Risk factors

    The analytical sample comprised 1481 NCI (76.7% female) and 515 MCI (69.7% female) participants.

  30. Structural and social determinants of dementia risk among adults racialized as Black: Results from a community‐based system dynamics approach

    ✓ Peer-reviewed alzhub usefulness score 49 out of 100. Alzheimer s & Dementia 2025-07-01 Risk factors

    CBSD revealed a framework for how economic hardship, especially low income and unemployment, reduces access to physical and mental healthcare, driving dementia risk.

  31. The Moderating Role of Dementia‐Related Fear in the Relationship Between Perceived Cognitive Decline and Motivation for Dementia Risk Reduction Behaviors in Community‐Dwelling Middle‐Aged and Older Adults

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. International Journal of Geriatric Psychiatry 2025-07-01 Prevention and risk

    A significant correlation was found between perceived cognitive decline and increased motivation to engage in dementia risk reduction behaviors (r = 0.44).

  32. Population Attributable Fraction of Modifiable Risk Factors for Dementia in Turkey

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Dementia 2025-06-29 Risk factors

    Dementia affects approximately 55 million people globally, with modifiable risk factors contributing significantly to its prevalence.

  33. Age-sex differences in Alzheimer’s and related dementias burden and risk factors in east and Southeast Asia: results from the 2021 GBD study

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Frontiers in Aging Neuroscience 2025-06-27 Risk factors

    The findings indicate that the burden of dementia is rising in East and Southeast Asia, with women showing a higher burden across all indicators.

  34. Statin Initiation and Dementia Incidence in a Large Health Care System From 1997 to 2020: A Target Trial Emulation Study

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Neurology 2025-06-27 Prevention and risk

    Among eligible participants (n = 705,061), 264,294 individuals (37.5% of eligible participants) initiated any statin during 2001-2010 ("initiators"), of whom 249,613 (94.4%) were matched with 255,937 unique noninitiators to create the analytic sample (322,358 unique participants; mean age at baseline = 67.4 years; 55.1% female).

  35. Evaluating Genomic and Clinical Risk Factors for Alzheimer's Disease in Individuals with Hypertension

    ✓ Peer-reviewed alzhub usefulness score 63 out of 100. Biomedicines 2025-06-26 Risk factors

    Obesity and Area Deprivation Index, a measure of socioeconomic status, were significantly associated with elevated AD risk within the hypertensive cohort.

  36. Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. npj Vaccines 2025-06-25 How common it is

    AS01-adjuvanted shingles (herpes zoster) vaccination is associated with a lower risk of dementia, but the underlying mechanisms are unclear.

  37. Dissecting the Interactions of Diabetes Mellitus and Hearing Loss with Cognitive Decline and Dementia

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Brain Sciences 2025-06-21 Risk factors

    The aging population is increasingly affected by both diabetes mellitus and hearing loss, two conditions that often coexist and can significantly impact quality of life.

  38. Sweetened Beverages and Incident All-Cause Dementia Among Older Adults

    ✓ Peer-reviewed alzhub usefulness score 56 out of 100. JAMA Psychiatry 2025-06-18 Brain tissue and pathology

    Of 10 974 participants (60.0% female, mean [SD] age: 73.2 [6.8] years), 2445 developed incident all-cause dementia over 116 067 person-years of follow-up.

  39. Lipoprotein(a) and risk of dementia: findings from three cohort studies

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. European Heart Journal 2025-06-17 How common it is

    On continuous scales, lipoprotein(a) levels were not associated with the risk of Alzheimer's disease or vascular-related dementia.

  40. Dose- and pattern- physical activity is associated with lower risk of dementia

    ✓ Peer-reviewed alzhub usefulness score 56 out of 100. Journal of Prevention of Alzheimer's Disease 2025-06-12 Prevention and risk

    Accumulating >300 min/week of MVPA, whether concentrated within 1-2 days or distributed evenly across the week, was associated with a decreased risk of dementia.

  41. Long-term exposure to air pollution and risk of dementia among older individuals of a Danish nationwide administrative cohort

    ✓ Peer-reviewed alzhub usefulness score 51 out of 100. Environment International 2025-06-12 Disparities

    Among 934,792 individuals, 81,731 developed dementia over a mean follow-up of 11·6 years.

  42. Metformin protects against insulin resistance-related dementia risk involving restored microglial homeostasis

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Life sciences 2025-06-08 Inflammation and the immune system

    Our findings suggest that metformin exerts therapeutic effects beyond glycemic control in the context of T2D. By mitigating neuroinflammation and modulating microglial autophagy, metformin emerges as a promising therapeutic agent for cognitive decline associated with diabetes and potentially other neurological disorders.

  43. Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on the Dementia Incidence in Patients With Type 2 Diabetes Mellitus: A Population‐Based Longitudinal Cohort Study

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Diabetes/Metabolism Research and Reviews 2025-06-07 How common it is

    Among a cohort comprising 109,778 individuals, the use of GLP-1RA demonstrated a reduced risk of dementia compared with its non-use (aHR, 0.90; 95% CI, 0.83-0.97).

  44. Economic Burden of Alzheimer Disease and Related Dementias by Race and Ethnicity, 2020 to 2060

    ✓ Peer-reviewed alzhub usefulness score 54 out of 100. JAMA Network Open 2025-06-05 Caregiving

    Of 31 028 older adults in MEPS, 5184 (10%) were African American; 146 (<1%) American Indian or Alaska Native; 1043 (3%) Asian (Indian, Chinese, or Filipino); 5346 (10%) Latino; 690 (2%) Other Asian, Native Hawaiian, and Pacific Islander; and 18 617 (75%) were White.

  45. Associations of accelerated biological ageing with incident dementia, cognitive functions and brain structure: a prospective cohort study based on UK Biobank

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Stroke and Vascular Neurology 2025-06-03 Long-term cohort studies

    During a median follow-up of 13.68 years, 4744 incident all-cause dementia (ACD) events (including 3013 Alzheimer's disease (AD) and 853 vascular dementia (VaD)) were recorded.

  46. Impact of APOE4‐related dementia risk in underrepresented groups from the All of Us research program

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Alzheimer s & Dementia 2025-06-01 Disparities

    There was a significantly higher risk of developing a dementia diagnosis in Hispanic/Latino and NHB participants than NHW participants and comparably increased dementia hazard ratios in the Hispanic/Latino, NHB, and NHW APOE4 carriers than non-carriers (hazard ratio [HR] [95% confidence interval {CI}] 1.54 [1.25-1.91], 1.25 [1.00-1.57], and 1.55 [1.40-1.72]).

  47. Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis

    ✓ Peer-reviewed alzhub usefulness score 61 out of 100. JAMA Neurology 2025-06-01 Prevention and risk

    Individuals with cannabis use severe enough to require hospital-based care were at increased risk of a new dementia diagnosis compared with those with all-cause hospital-based care or the general population.

  48. Medications associated with dizziness or hypotension and adverse outcomes: an electronic health record study in older adults with dementia

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Age and Ageing 2025-05-31 Clinical safety

    Of the patients, 82.2% were receiving at least one dizziness-associated medication and 71.2% at least one hypotension-associated medication.

  49. A novel risk factor for dementia: chronic microplastic exposure

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in Neurology 2025-05-30 Digital health tools

    Recent advances in dementia research have expanded our understanding of modifiable risk factors, with air pollution being a well-established contributor.

  50. Hypertension and diabetes on cognitive impairment: a case–control study in China

    ✓ Peer-reviewed alzhub usefulness score 56 out of 100. Alzheimer s Research & Therapy 2025-05-30 Risk factors

    We found significant impacts of hypertension, diabetes and their comorbidity on cognitive impairment occurrence.

From across this tag

10 of the 1,134 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

All topic tags with their study counts